Nephrologic Disorders and COVID-19: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→AKI) |
||
| Line 10: | Line 10: | ||
==Complications== | ==Complications== | ||
===AKI=== | ===AKI=== | ||
====Pathophysiology==== | |||
====Clinical Features of AKI by SARS-CoV-2==== | ====Clinical Features of AKI by SARS-CoV-2==== | ||
====Treatment==== | ====Treatment==== | ||
Revision as of 02:49, 22 June 2020
To go to the COVID-19 project topics list, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2] Nasrin Nikravangolsefid, MD-MPH [3]